Monthly Investment Guide: Wegovy V Mounjaro Cost Planning
Wegovy V Mounjaro Monthly Cost: Essential Budgeting Differences
Understanding the monthly financial commitment for Wegovy versus Mounjaro requires examining each medication's unique dose escalation schedule and pricing structure. Wegovy follows a structured 16-week escalation from 0.25mg to the maintenance dose of 2.4mg, with monthly costs ranging from £79.99 to £209.99. This predictable progression allows patients to budget effectively for their weight management journey.
Mounjaro follows a different escalation timeline and pricing model, reflecting its dual GIP+GLP-1 receptor agonist mechanism compared to Wegovy's single GLP-1 approach. The choice between these treatments should consider both clinical suitability and long-term affordability. Both medications are prescription-only medicines requiring ongoing clinical supervision and work most effectively alongside lifestyle modifications.
Wegovy V Mounjaro Pricing: Detailed Monthly Breakdown
Wegovy's monthly cost structure follows a clear progression: £79.99 for the 0.25mg starter dose (weeks 1-4), £94.99 for 0.5mg (weeks 5-8), £99.99 for 1mg (weeks 9-12), £139.99 for 1.7mg (weeks 13-16), and £209.99 for the 2.4mg maintenance dose. New customers apply code FIRST40 at checkout, whilst returning customers use DOSE25 for ongoing savings. The annual maintenance cost at 2.4mg totals approximately £2,520, providing clear budgeting guidance.
Bundle options can reduce ordering frequency whilst ensuring consistent supply. The Ultimate Stability Trio provides three months of 2.4mg maintenance supply for £649.99, whilst the Intro Trio (0.25mg, 0.5mg, 1mg) covers your first three dose levels for £299.99. These bundles offer convenience and supply security rather than price reduction, ensuring uninterrupted treatment progression.
Clinical Evidence: Wegovy V Mounjaro Treatment Outcomes
In clinical trials, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks in the STEP 1 trial (Wilding et al., NEJM, 2021). The STEP programme demonstrated consistent efficacy across different patient populations, with STEP 2 showing clinically studied weight loss in patients with type 2 diabetes.
Mounjaro's clinical evidence comes from the SURMOUNT trial programme, demonstrating its dual GIP+GLP-1 mechanism. Both medications show robust clinical evidence, though direct comparison requires careful consideration of different trial designs and patient populations. Your prescriber can help determine which treatment aligns with your clinical profile and treatment goals.
How Wegovy Works: GLP-1 Mechanism In Wegovy V Mounjaro Comparison
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the natural fullness hormone GLP-1. This mechanism reduces appetite by acting on brain appetite centres whilst promoting feelings of fullness after smaller meals. The once-weekly injection helps regulate glucose-dependent insulin release and slows gastric emptying, contributing to sustained satiety. Mounjaro's tirzepatide targets both GIP and GLP-1 receptors, creating a dual agonist approach to weight management. Understanding these mechanistic differences helps explain the varying cost structures and dose escalation schedules between the treatments.
Ordering Process: Wegovy V Mounjaro Clinical Assessment
Both Wegovy and Mounjaro require identical clinical assessment processes through EverydayMeds' GPhC-registered pharmacy (#9012878). The three-minute online clinical assessment covers your medical history, current medications, and weight management goals. Prescriber review typically takes three working days, with express 24-hour review available for urgent cases. Once approved, next-day delivery ensures your medication arrives in temperature-controlled, cold-chain packaging. This standardised process applies whether you choose Wegovy or Mounjaro, with pricing being the primary differentiator rather than access procedures.
Storage Advantages: Wegovy V Mounjaro Practical Considerations
Wegovy offers superior storage flexibility compared to Mounjaro, remaining stable at room temperature for six weeks versus Mounjaro's 21-day limit. Both medications require refrigeration at 2-8°C before first use and utilise pre-filled FlexTouch pen devices for convenient weekly injections. The extended room temperature stability makes Wegovy more suitable for frequent travellers or those with limited refrigeration access. Dose escalation follows manufacturer protocols for both treatments, with Wegovy's 16-week progression to maintenance dose being well-established in clinical practice. This storage advantage may influence long-term treatment adherence and convenience, factors worth considering alongside monthly costs.
Long-Term Cost Planning: Wegovy V Mounjaro Financial Strategy
Effective budgeting for either Wegovy or Mounjaro requires understanding the transition from escalation to maintenance phases. Wegovy's maintenance cost of £209.99 monthly represents the ongoing investment required for sustained weight management. The STEP 1 extension study showed patients regained approximately two-thirds of weight lost within one year of stopping treatment, emphasising the importance of long-term financial planning.
Annual maintenance costs should factor into treatment decisions, with potential savings through bundle purchases and discount codes. Both treatments represent significant financial commitments, but the health benefits and cardiovascular risk reduction demonstrated in clinical trials may offset long-term healthcare costs. Your prescriber can discuss treatment duration expectations and help develop a sustainable financial strategy for your chosen medication.
Making Your Choice: Wegovy V Mounjaro Decision Framework
Choosing between Wegovy and Mounjaro involves balancing clinical suitability, monthly costs, and practical considerations like storage requirements. Both treatments are available through EverydayMeds' clinical assessment process, with transparent pricing and ongoing prescriber support. The decision should prioritise clinical appropriateness over cost alone, as treatment efficacy varies between individuals. Your prescriber can evaluate your medical history, previous weight management attempts, and concurrent medications to recommend the most suitable option. EverydayMeds provides ongoing clinical support throughout your treatment journey, ensuring optimal outcomes regardless of your chosen medication.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
